✦ LIBER ✦

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

✍ Scribed by David Neal Franz; Jennifer Leonard; Cynthia Tudor; Gail Chuck; Marguerite Care; Gopalan Sethuraman; Argirios Dinopoulos; George Thomas; Kerry R. Crone

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 770 KB
Volume: 59
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.20784

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metastasis of benign tumor cells in tube

Metastasis of benign tumor cells in tuberous sclerosis complex

✍ Elizabeth Petri Henske 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract Lymphangiomyomatosis (LAM) is a life‐threatening lung disease affecting almost exclusively young women. Histologically, LAM is characterized by the diffuse, bilateral proliferation of abnormal smooth muscle cells and cystic degeneration of the lung parenchyma. LAM can occur as an isolat

Functional assessment of TSC1 missense v

Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex

✍ Marianne Hoogeveen-Westerveld; Rosemary Ekong; Sue Povey; Izabela Karbassi; Sat 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

Combination of a rapamycin analog (CCI-7

Combination of a rapamycin analog (CCI-779) and interferon-γ is more effective than single agents in treating a mouse model of tuberous sclerosis complex

✍ Laifong Lee; Paul Sudentas; Sandra L. Dabora 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB

## Abstract Tuberous sclerosis complex (TSC) is a familial tumor syndrome characterized by the development of hamartomas in the brain, heart, kidney, and skin. Disease‐causing mutations in the __TSC1__ or __TSC2__ gene result in constitutive activation of the highly conserved mTOR signal transducti

Sacrococcygeal chordomas in patients wit

Sacrococcygeal chordomas in patients with tuberous sclerosis complex show somatic loss of TSC1 or TSC2

✍ Lisa Lee-Jones; Irene Aligianis; Peter A. Davies; Ana Puga; Peter A. Farndon; An 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB

Chordomas are rare sacrococcygeal/sacral, sphenooccipital/clivus, and spinal tumors whose molecular etiology remains relatively understudied. As several anecdotal reports had described chordomas in individuals with tuberous sclerosis complex (TSC), a multisystem hamartoma syndrome, we hypothesized t

Functional assessment of variants in the

Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with Tuberous Sclerosis Complex

✍ Marianne Hoogeveen-Westerveld; Marjolein Wentink; Diana van den Heuvel; Melika M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB

The effects of missense changes and small in-frame deletions and insertions on protein function are not easy to predict, and the identification of such variants in individuals at risk of a genetic disease can complicate genetic counselling. One option is to perform functional tests to assess whether

Malignant tumors of the kidney, brain, a

Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex

✍ Tahseen Al-Saleem; Lisa L. Wessner; Bernd W. Scheithauer; Kathleen Patterson; E. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 927 KB

## BACKGROUND. The tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by seizures, mental retardation, and benign tumors of the brain, heart, skin, and kidney. Malignant tumors also can occur in patients with tuberous sclerosis, particularly in the kidney, although the